Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate)

Journal of Orthopaedic Research

Volumn 18, Issue 5, 2000, Pages 734-738

  Pysklywec, Michael W ^a   Moran, Erica L ^a   Bogoch, Earl R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; CELLS; DISEASES; FRACTURE FIXATION; MEDICAL IMAGING; ORTHOPEDICS;

BIPHOSPHONATE; DISTAL FEMORAL METAPHYSIS; INFLAMMATORY ARTHRITIS;

BONE;

ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; FEMUR; GEOMETRY; IMAGE ANALYSIS; METAPHYSIS; NONHUMAN; POROSITY; PRIORITY JOURNAL; RABBIT; RHEUMATOID ARTHRITIS;

EID: 0034269241     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100180509     Document Type: Article

References (34)

1. Variation in the density of the femoral diaphysis with age
2. Bisphosphonate (Pamidronate/APD) prevents arthritis-induced loss of fracture toughness in the rabbit femoral diaphysis
3. Juxta-articular bone loss in experimental inflammatory arthritis
4. Changes in the metaphysis and diaphysis of the femur proximal to the knee in rabbits with experimentally induced arthritis
5. Arthritis not immobilization causes bone loss in the carrageenan injection model of inflammatory arthritis
6. Two modes of action of bisphosphonates on osteoclast resorption of mineralized matrix
7. Growth disturbances in experimental juvenile arthritis of the dog knee
8. Haemodynamics in acute arthritis of the knee in puppies
9. Fractal dimension as a measure of altered trabecular bone in experimental inflammatory arthritis
10. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
11. Rheumatoid arthritis, corticosteroid therapy, and hip fracture
12. Bone tissue in rheumatoid arthritis (1). Bone mineral density and fracture risk
13. Influence of muscle forces on femoral strain distribution
14. Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates
15. Non-destructive imaging of arthritic and normal rabbit femoral distal metaphyses using five different high-resolution imaging techniques
16. An evaluation of three loading configurations for the in vitro testing of femoral strains in total hip arthroplasty
17. Generalised bone loss in patients with early rheumatoid arthritis
18. Preclinical pharmacology of CGP 42'446, a new, potent heterocyclic bisphosphonate compound
19. The effect of rheumatoid arthritis on subchondral bone
20. Osteonal parameters in experimental inflammatory arthritis and treatment with zoledronate in rabbits
21. Fractures after rheumatoid arthritis: A population based study
22. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
23. Bone changes induced in a rabbit model of experimental arthritis
24. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins including Ras
25. The incidence of fracture of the proximal femur in two million Canadians from 1972 to 1984
26. Age and sex-related changes in the structure and strength of the human femoral shaft
27. Studies of skeletal remodeling in aging men
28. Light and electron microscope studies in carragheenin, adjuvant and tuberculin-induced arthritis
29. Altered pore characteristics and geometry in diaphyseal cortical bone affected by inflammatory arthritis
30. Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis
31. Theoretical relationship between maximum pore size and toughness in experimental inflammatory arthritis
32. Bisphosphonates: Mechanisms of action
33. Overview of bisphosphonates
34. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro